Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients-Reference-Cited by-同舟云学术

Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients

Published:2001-10 Issue:7 Volume:28 Page:657-664
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Sandström M,Karlsson MO,Ljungman P,Hassan Z,Jonsson EN,Nilsson C,Ringden O,Öberg G,Bekassy A,Hassan M

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1703229.pdf

Reference35 articles.

1. Copelan EA, Biggs JC, Thompson JM et al. Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2 Blood 1991 78: 838–843

2. Lu C, Braine HG, Kaizer H et al. Preliminary results of high-dose busulfan and cyclophosphamide with syngeneic or autologous bone marrow rescue Cancer Treat Rep 1984 68: 711–717

3. Geller RB, Saral R, Piantadosi S et al. Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemia Blood 1989 73: 2209–2218

4. Santos GW, Tutschka PJ, Brookmeyer R et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide New Engl J Med 1983 309: 1347–1353

5. Slattery JT, Clift RA, Buckner CD et al. Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation Blood 1997 89: 3055–3060

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model-Informed Precision Dosing of Intravenous Busulfan in Thai Pediatrics Undergoing Hematopoietic Stem Cell Transplantation;Therapeutic Drug Monitoring;2024-05-14

2. Saliva as a noninvasive sampling matrix for therapeutic drug monitoring of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation: A prospective population pharmacokinetic and simulation study;CPT: Pharmacometrics & Systems Pharmacology;2023-07-25

3. Predicting busulfan exposure in patients undergoing hematopoietic stem cell transplantation using machine learning techniques;Expert Review of Clinical Pharmacology;2023-06-20

4. New dosing nomogram and population pharmacokinetic model for young and very young children receiving busulfan for hematopoietic stem cell transplantation conditioning;Pediatric Blood & Cancer;2020-07-24

5. Modelling of neutrophil dynamics in children receiving busulfan or treosulfan for haematopoietic stem cell transplant conditioning;British Journal of Clinical Pharmacology;2020-03-03